B. Riley has revised its price target for IperionX (IPX, Financial), reducing it from $30 to $28 while maintaining a Buy rating for the company's stock. This adjustment comes as IperionX continues to advance its titanium production at its Virginia facility. The company is aiming to achieve full operational capacity by mid-2025.
In the latest assessment, the analyst has adopted a more cautious view on the pace of this production scale-up. Despite the reduced price target, IperionX's future growth prospects remain positive according to B. Riley, supported by the ongoing developments at the titanium manufacturing site.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 3 analysts, the average target price for IperionX Ltd (IPX, Financial) is $27.33 with a high estimate of $32.00 and a low estimate of $20.00. The average target implies an upside of 40.17% from the current price of $19.50. More detailed estimate data can be found on the IperionX Ltd (IPX) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, IperionX Ltd's (IPX, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
